← FDA Drug Approvals (Drugs@FDA)

CAMCEVI ETM

NDA · New Drug Application · Sponsor: ACCORD · Approved 2025-08-25

Drug application

FDA Application #

NDA219745

Application type

New Drug Application

Brand name

CAMCEVI ETM

Generic name

Leuprolide Mesylate

Active ingredients

LEUPROLIDE MESYLATE

Dosage form

EMULSION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ACCORD

First approval

2025-08-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown